Pernod Ricard (EPA: RI) falls 7.2% as US and China sales slump deepens

Pernod Ricard S.A. (Euronext Paris: RI) fell 7.2% on August 27 after the French spirits group reported declining fiscal 2026 sales and profit while warning that weakness in the United States could keep growth near the bottom of its long-term target range through fiscal 2029. Organic sales fell 3.9% to €9.404 billion, profit from recurring operations declined 5.2% organically to €2.423 billion and recurring net profit fell 19% to €1.476 billion. The United States declined 14% and China fell 19%, overwhelming 7% growth in India and improving trends across several smaller markets. RI closed around €62.72, leaving the stock close to the bottom of its 52-week range and forcing investors to decide whether a roughly 11 times earnings valuation compensates for weak demand, €10.7 billion of net debt and a turnaround that may take several years.

Why did Pernod Ricard shares fall more than 7% after FY26 results?

Pernod Ricard’s headline numbers confirmed that the spirits downturn remains deeper and more geographically concentrated than investors hoped. Organic net sales declined 3.9%, while reported revenue fell 14.2% because foreign exchange movements and portfolio changes added another substantial drag.

Profit from recurring operations fell 5.2% organically and 17.9% on a reported basis to €2.423 billion. Recurring group net profit dropped 19% to €1.476 billion, reported group net profit declined 26% to €1.203 billion and earnings per share fell 19% to €5.85.

The deterioration was concentrated in the two markets that historically mattered most to the premiumisation story. U.S. sales declined 14% as consumer confidence remained subdued and distributors adjusted inventories, while China sales fell 19% as weak consumer sentiment and regulatory changes continued pressuring premium cognac and prestige categories.

The share price reflected concerns about duration rather than merely the FY26 decline. RI closed around €62.72 on August 27 compared with €67.60 the previous day, putting the stock about 8.8% below its August 20 close and only around 7% above the 52-week low of €58.62. The shares remain more than 40% below the 52-week high of €107.40, indicating that the market has already removed a substantial portion of Pernod Ricard’s historical premium.

Why are the United States and China so difficult to replace?

Pernod Ricard owns more than 240 premium brands and sells across more than 160 markets, giving it one of the industry’s broadest geographical portfolios. That diversification helped the group produce organic growth of 0.5% when the United States and China are excluded, but it was not enough to compensate for the scale of weakness in those two markets.

The United States is experiencing both cyclical and structural pressures. Economic moderation and subdued consumer confidence are reducing demand, while younger consumers are changing drinking occasions and showing greater interest in ready-to-drink products and moderation. Pernod Ricard’s U.S. sell-out declined around 7% for the full year, meaning the 14% reported organic sales decline was also affected by inventory adjustments and route-to-market changes rather than consumer demand alone.

China presents a different problem because the highest-value cognac and prestige categories have been particularly weak. Martell has substantial exposure to those segments, while regulatory measures and subdued discretionary spending have reduced demand. Management indicated some cautious improvement in trade sentiment before the Mid-Autumn Festival, but the full-year decline shows that a meaningful recovery cannot yet be treated as the base case.

The combined weakness changes the value of growth elsewhere. India increased 7%, or 9% excluding the disposed Imperial Blue business, while markets including Canada, Japan, Türkiye and parts of Africa performed well. Those markets are becoming increasingly important, but replacing billions of euros of revenue exposure in the United States and China requires sustained expansion over several years rather than one or two strong quarters.

Can India become Pernod Ricard’s next major growth engine?

India was one of the clearest bright spots in FY26. Organic sales rose 7%, with strong demand for local whisky brands including Royal Stag and Blenders Pride and double-digit growth across selected international brands such as Jameson.

The strategic importance of India has increased further after Pernod Ricard sold Imperial Blue and improved the quality of the remaining portfolio. Management said the disposal is immediately accretive to both margin and growth, while India has now become the group’s second-largest market.

Pernod Ricard has also confirmed that discussions are taking place around a potential Indian initial public offering. A listing could crystallise value in a business benefiting from premiumisation, rising legal-drinking-age populations and expanding disposable income, although no final structure or timetable has been announced.

The India opportunity should nevertheless be kept in proportion. Maharashtra excise-policy changes began weighing on sales from July, and India’s highly regulated state-by-state alcohol market creates operational complexity. The stronger long-term case is therefore not that India instantly replaces China, but that it becomes a progressively larger growth pillar while the rest of the portfolio reduces dependence on any one premium market.

Can €1bn of cost savings protect profit while sales remain weak?

Pernod Ricard’s cost programme is doing meaningful work. The company has already delivered approximately half of its €1 billion Operational Efficiencies target and now expects the entire programme to be completed by fiscal 2028, one year earlier than initially planned.

Structure costs declined 8% organically during FY26 after falling 4% in the previous year. Advertising and promotion represented approximately 15% of sales, at the lower end of management’s historical range, while operating margin declined only 35 basis points organically despite negative price mix, tariffs and input-cost inflation.

These savings explain why profit did not fall as quickly as reported revenue. They also create a clear limitation because costs cannot be reduced indefinitely without eventually affecting brand support, commercial execution or organisational capability.

Management is attempting to avoid that trade-off by protecting consumer-facing investment while simplifying the organisation. The Fit for Future programme has contributed to roughly 3,600 role reductions since 2024, and the wider restructuring is designed to simplify decision-making while keeping marketing support behind priority brands.

The next evidence investors need is operating-margin stability rather than another headline cost-savings figure. If organic sales remain weak but the margin holds around current levels while free cash flow improves, Pernod Ricard can deleverage and preserve strategic flexibility. If margins continue falling despite the €1 billion programme, the earnings base will become considerably harder to defend.

Does €10.7bn of net debt limit Pernod Ricard’s options?

Net debt ended FY26 at €10.662 billion, down only €65 million from a year earlier. Because EBITDA declined, the net debt to EBITDA ratio increased to 3.7 times, placing balance-sheet repair near the centre of the investment debate.

Cash generation improved. Free cash flow increased 6% to €1.197 billion and cash conversion rose 17 percentage points to 91%, supported by tighter working-capital management, lower strategic inventories and reduced capital expenditure.

The board is proposing an unchanged €4.70 annual dividend, including a €2.35 final payment that shareholders can elect to receive in cash or shares. At the August 27 share price, the proposed annual dividend represents a yield of roughly 7.5%, which is unusually high for a company with Pernod Ricard’s brand portfolio and historical quality profile.

That yield should not automatically be interpreted as cheap income. A high dividend yield often reflects market concern about whether a payout can be sustained while leverage remains elevated. The company has said its financial policy must balance growth investment, deleveraging and shareholder returns, making progress on net debt one of the clearest indicators to monitor during FY27.

Is Pernod Ricard cheap near €63 after the sell-off?

With approximately 251.7 million shares outstanding, a price around €62.72 gives Pernod Ricard an equity value of roughly €15.8 billion. Adding €10.7 billion of net debt means enterprise value remains much larger than the headline equity valuation, which is why leverage cannot be separated from the apparent cheapness of the shares.

FY26 EPS of €5.85 produces a trailing P/E of approximately 10.7 times. That is substantially below the multiples investors historically assigned to large global premium-spirits companies when China demand, U.S. premiumisation and margin expansion were all moving in the same direction.

The question is whether FY26 earnings represent a trough. Pernod Ricard now expects medium-term growth through 2029 to be toward the lower end of its 3% to 6% organic sales objective, while management has indicated that FY27 will begin slowly, particularly in Q1.

A recovery therefore does not require investors to assume a rapid return to the old growth model. The case becomes attractive if the group can stabilise U.S. demand, stop the decline in China, maintain Indian momentum and convert the remaining €500 million of efficiency savings into profit and cash. If the U.S. decline proves structural and China remains weak, a 10 to 11 times earnings multiple could persist because the sustainable growth rate would be lower than investors once expected.

Pernod Ricard stock key takeaways after the FY26 sell-off

• Pernod Ricard shares fell about 7.2% to €62.72 after FY26 organic sales declined 3.9% and recurring operating profit fell 5.2% organically.
• The United States declined 14% and China fell 19%, while India grew 7% and sales excluding the U.S. and China increased 0.5%.
• Profit from recurring operations was €2.423 billion, recurring group net profit fell 19% to €1.476 billion and EPS declined to €5.85.
• Pernod Ricard has already delivered around half of its €1 billion efficiency programme and expects full delivery by FY28, while structure costs fell 8% during FY26.
• Free cash flow improved 6% to €1.197 billion, but net debt remains €10.662 billion and leverage increased to 3.7 times EBITDA because earnings declined.
• At around €62.72, RI trades at approximately 10.7 times FY26 EPS and offers a roughly 7.5% yield on the proposed €4.70 dividend, with the high yield reflecting meaningful growth and leverage concerns.

What would strengthen or weaken the Pernod Ricard investment case?

The investment case would strengthen if the U.S. sell-out decline continues narrowing, China shows evidence of stabilisation around major consumption periods and India maintains high-single-digit growth after the Imperial Blue disposal. Continued margin protection while the remaining €500 million of efficiency savings are implemented would provide another important signal that Pernod Ricard can restore earnings without waiting for every major geography to recover simultaneously.

A meaningful reduction in net debt would also change the valuation debate because it would reduce the tension between the dividend, investment spending and balance-sheet discipline. Successful progress toward a potential Indian listing could provide an additional route to crystallise value from one of the group’s strongest businesses.

The thesis would weaken if the United States remains in double-digit decline, Chinese prestige demand deteriorates further or the cost programme begins reducing marketing effectiveness. A dividend reduction would not necessarily damage long-term value if it accelerates deleveraging, but it would confirm that the current 7.5% yield was not a dependable measure of shareholder return.

Pernod Ricard is now priced much more like a slow-growth consumer company than the premium global compounder investors once believed they owned. The opportunity is that the brand portfolio, India growth, €1 billion efficiency programme and eventual normalisation in the United States and China restore earnings while the valuation remains depressed. The risk is that the market has correctly identified a structural change in alcohol consumption that makes the old growth assumptions permanently too optimistic.